FASN and cancer: mTOR can affect cancer cell lipid metabolism by activating OXPHOS that in turn promote lipogenesis [114], as recently demonstrated by the evidence of downregulation of lipogenic enzymes, including FASN, acetyl-CoA carboxylase 1 and ATP citrate lyase, following treatment with mTOR inhibitor or by raptor genetic knockdown [111,115].